Meltem Tan Uygun

Meltem Tan Uygun

Auto-generated profile, based on publicly available information

Meltem Tan Uygun

Van Yüzüncü Yıl Üniversitesi

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Heteroatom Chemistry
Verified
Journal Article
Closed access
PDF file
BKBurak Kuzu
Burak Kuzu
HGHasan Genç
Hasan Genç
MTMehmet Taşpinar
Mehmet Taşpinar
MTMeltem Tan
Meltem Tan
NMNurettin Menges
Nurettin Menges

2 January 2021 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
MUMeltem Tan Uygun
Meltem Tan Uygun
KAKarina Amudi
Karina Amudi
İTİrem Doğan Turaçlı
İrem Doğan Turaçlı
NMNurettin Menges
Nurettin Menges

1 January 2018 in Journal of the Serbian Chemical Society
Verified
Journal Article
Open access
PDF file
MTMeltem Tan
Meltem Tan
IBIshak Bildirici
Ishak Bildirici
NMNurettin Mengeş
Nurettin Mengeş
In this article, a series asymmetric aryl 1,3-dicarbonyl compounds have been synthesized and their observed enol forms have been studied via experimental data and theoretical calculations. According to the 1H and 13C NMR, all investigated compounds have been found into single enol form in the CDCl3 solution. Moreover, HMBC spectra were applied to identify observed enol forms in which correlations between certain proton and carbon atoms were considered. Dihedral angles of asymmetric compounds which have aryl units on both sides were calculated by DFT to understand the reason of observed enol forms. Small dihedral angles caused longer conjugation resulting in more stable compounds and it was found that observed enol form was based on small dihedral angles, namely, resonance driving force. Furthermore, the compounds possessing both aryl and alkyl moieties prefer enol form towards the aromatic ring side due to longer conjugation.

24 March 2026 in ACS Omega
Verified
Journal Article
Open access
EAEda Acikgoz
Eda Acikgoz
MCMustafa Cakir
Mustafa Cakir
BKBurak Kuzu
Burak Kuzu
MTMeltem Tan-Uygun
Meltem Tan-Uygun
A novel indole-fused benzimidazole fluorescent probe, I-BZ, was designed, synthesized, and characterized for selective imaging of intracellular lipid droplets (LDs) in human breast cancer cells (MDA-MB-231). The probe was prepared via condensation of 3-methyl-1H-indole-2-carbaldehyde with 4-methylbenzene-1,2-diamine and confirmed by 1H/13C NMR and LC-MS/MS. Photophysical studies indicated that I-BZ exhibits ESIPT-based fluorescence, enabling sensitive detection of lipid-rich compartments. Cytotoxicity assays showed that low concentrations (0.5 μM) were biocompatible for live-cell imaging, whereas higher doses exhibited anticancer activity, with IC50 values of 35 μM at 24 h and 15 μM at 48 h. Fluorescence microscopy in fixed and live cells demonstrated selective accumulation of I-BZ in LDs, validated by ethanol disruption and colocalization with Nile Red. Nuclear costaining with DAPI provided spatial context for precise visualization of cytoplasmic LDs. I-BZ shows great potential as a fluorescent probe for lipid droplet imaging, offering a robust tool for investigating lipid-associated processes in cancer biology.


5 January 2026 in Current Eye Research
Verified
Journal Article
Closed access
RTRumeysa Bilmez Tan
Rumeysa Bilmez Tan
STSerek Tekin
Serek Tekin
ZIZehra Akman ilik
Zehra Akman ilik
MBMuhammed Batur
Muhammed Batur
ESErbil Seven
Erbil Seven
MUMeltem Tan Uygun
Meltem Tan Uygun
To evaluate the therapeutic effects of bakuchiol on clinical and histopathological outcomes in a rat model of corneal alkali burn. Corneal alkali burns were induced in the right eyes of 35 male Wistar rats, which were randomized into five groups: control, carbomer, steroid, 0.14 mg/g bakuchiol, and 0.28 mg/g bakuchiol. Examinations were performed under stereomicroscopy with intraperitoneal ketamine anesthesia on days 0, 3, 7, and 14 to assess corneal epithelial defects and opacity; on day 14, corneal neovascularization was additionally evaluated. After the final examination, the eyes were enucleated, and the corneas were processed for hematoxylin-eosin and immunohistochemical staining. Epithelial necrosis, inflammatory cell density, corneal hemorrhage, stromal edema, and staining intensity for VEGF and TNF-α were semi-quantitatively scored. Bakuchiol treatment, particularly at 0.28 mg/g, significantly reduced corneal opacity, neovascularization, hemorrhage, and stromal edema compared with the steroid-treated group. Bakuchiol demonstrated promising anti-inflammatory and anti-angiogenic effects and may represent a potential adjunctive treatment for corneal chemical injuries.